Angiotensin I-converting enzyme insertion-related genotypes and allele are associated with higher susceptibility of endometriosis and leiomyoma

Molecular Reproduction and Development

Volumn 74, Issue 7, 2007, Pages 808-814

  Hsieh, Yao Yuan ^a,b   Lee, Cheng Chun ^a   Chang, Chi Chen ^a   Wang, Yu Kuo ^b   Yeh, Lian Shun ^a   Lin, Chich Sheng ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Angiotensin I converting enzyme, ACE; Endometriosis; Leiomyoma; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ALLELE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDOMETRIOSIS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; INTRON; LEIOMYOMA; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEIOMYOMA; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; TAIWAN;

EID: 34249801779     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20474     Document Type: Article

References (75)

1. Abbud ZA, Wilson AC, Cosgrove NM, Kostis JB. 1998. Angiotensin-converting enzyme gene polymorphism in systemic hypertension. Am J Cardiol 81:244-246.
2. Alvarez R, Terrados N, Ortolano R, Iglesias-Cubero G, Reguero JR, Batalla A, Cortina A, Fernandez-Garcia B, Rodriguez C, Braga S, Alvarez V, Coto E. 2000. Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol 82:117-120.
3. Anderson TI, Heimdal KR, Skrede M, Tveit K, Berg K, Borresen AL. 1994. Oestrogen receptore (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 94:665-670.
4. Arkwright PD, Pravica V, Geraghty PJ, Super M, Webb AK, Schwarz M, Hutchinson IV. 2003. End-organ dysfunction in cystic fibrosis: Association with angiotensin I converting enzyme and cytokine gene polymorphisms. Am J Respir Crit Care Med 167:384-389.
5. Bachman J, Feldmer M, Ganten U, Stock G, Ganten D. 1991. Sexual dimorphism of blood pressure: Possible role of the renin angiotensin system. J Steroid Biochem Mol Biol 40:511-515.
6. Baudin B. 2002. Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomics considerations. Pharmacogenomics 3: 65-73.
7. Berge KE, Berg K. 1994. No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 45:169-174.
8. Bloem LJ, Manatunga AK, Pratt JH. 1996. Racial difference in the relationship of an angiotensin I-oonverting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 27:62-66.
9. Boehm KD, Daimon M, Gorodeski IG, Sheean LA, Utian WH, Ilan J. 1990. Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol Reprod Dev 27:93-101.
10. Braileanu GT, Simasko SM, Hu J, Assiri A, Mirando MA. 2001. Effects of arginine- and lysine-vasopressin on phospholipase C activity, intracellular calcium concentration and prostaglandin F2alpha secretion in pig endometrial cells. Reproduction 121:605-612.
11. Braileanu GT, Simasko SM, Speth RC, Daubert DC, Hu J, Mirando MA. 2002. Angiotensin II increases intracellular calcium concentration in pig endometrial stromal cells through type 1 angiotensin receptors, but does not stimulate phospholipase C activity or prostaglandin F2alpha secretion. Reprod Fertil Dev 14:199-205.
12. Cambien F. 1994. The angiotensin-converting enzyme (ACE) genetic polymorphism: Its relationship with plasma ACE level and myocardial infarction. Clin Genet 46:94-101.
13. Chang HR, Cheng CH, Shu KH, Chen CH, Lian JD, Wu MY. 2003. Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. J Chin Med Assoc 66:51-56.
14. Choi YH, Kim JH, Kim DK, Kim JW, Kim DK, Lee MS, Kim CH, Park SC. 2003. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians. J Gerontol A Biol Sci Med Sci 58:227-231.
15. Cramer DW. 1992. Epidemiology of myomas. Semin Reprod Endocrinol 10:320-324.
16. Di Lieto A, De Rosa G, Albano G, Staibano S, Campanile M, Pontillo M, Gallo F, Micalef R, Paladini A. 1997. Influence of goserelin depot therapy on epidermal growth factor receptor expression in pelvic endometriosis. Gynecol Endocrinol 11:17-20.
17. Di Lieto A, De Falco M, Pollio F, Mansueto G, Salvatore G, Somma P, Ciociola F, De Rosa G, Staibano S. 2005. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas. J Soc Gynecol Investig 12:123-128.
18. Dinh D, Frauman AG, Johnston CI, Fabiani ME. 2001. Angiotensin receptors: Distribution, signaling and function. Clin Sci 100: 481-92.
19. Dixit M, Mansur A, Dixit N, Gilman J, Santarina L, Glicklich D. 2002. The role of ACE gene polymorphism in rapidity of progression of focal segmental glomerulosclerosis. J Postgrad Med 48:266-269.
20. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. 1998. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 13:1686-1690.
21. Doria A, Warram JH, Rich SS, Krolewski AS. 1994. Angiotensin I-converting enzyme (ACE): Estimation of DNA haplotypes in unrelated individuals using denaturing gradient gel blots. Hum Genet 94:117-123.
22. El-Badry OM, Helman LJ, Chatten J, Steinberg SM, Evans AE, Israel MA. 1991. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 87:648-657.
23. Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E. 1998. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 97:1773-1779.
24. Foy CA, Rice GI, Ossei-Gerning N, Mansfield MW, Grant PJ. 1997. Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography. Hum Genet 100: 420-425.
25. Freitas-Silva M, Pereira D, Coelho C, Bicho M, Lopes C, Medeiros R. 2004. Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet 155:42-46.
26. Goldman MB, Cramer DW. 1989. Current concepts in endometriosis. Prog Clin Biol Res 323:17-23.
27. Haiman CA, Henderson SO, Bretsky P, Kolonel LN, Henderson BE. 2003. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: The multiethnic cohort. Cancer Res 63:6984-6987.
28. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJ, Watt GC. 1993. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 21:455-460.
29. Henskens LH, Spiering W, Stoffers HE, Soomers FL, Vlietinck RF, de Leeuw PW, Kroon AA. 2003. Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: First results of the Hippocates study. J Hypertens 21:81-86.
30. Hii SI, Nicol DL, Gotley DC, Thompson LC, Green MK, Jonsson JR. 1998. Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma. Br J Cancer 77:880-883.
31. Hiramori K. 1994. Treatment of acute myocardial infarction. Nippon Naika Gakkai Zasshi 83:455-459.
32. Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin CC, Tsai CH. 2005. Angiotensin I-converting enzyme ACE 2350*G and ACE-240*T-related genotypes and alleles are associated with higher susceptibility to endometriosis. Mol Hum Reprod 11:11-14.
33. Inan S, Kuscu NK, Vatansever S, Ozbilgin K, Koyuncu F, Sayhan S. 2003. Increased vascular surface density in ovarian endometriosis. Gynecol Endocrinol 17:143-150.
34. Irahara M, Uemura H, Yasui T, Kinoshita H, Yamada M, Tezuka M, Kiyokawa M, Kamada M, Aono T. 2001. Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis. Gynecol Obstet Invest 52: 217-222.
35. Isbir T, Yilmaz H, Agachan B, Aydin M, Isbir CS. 1999. Association between angiotensin-converting enzyme gene polymorphism and coronary artery disease. IUBMB Life 48:205-207.
36. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, de Faire U, Cairns NJ, Wilcock GK, Brookes AJ, et al. 2003. Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 12:859-867.
37. Kennon B, Ingram MC, Friel EC, Anderson NH, MacKenzie SM, Davies E, Shakerdi L, Wallace AM, Fraser R, Connell JM. 2004. Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clin Endocrinol (Oxf) 61:174-181.
38. Koh WP, Yuan JM, Sun CL, van den Berg D, Seow A, Lee HP, Yu MC. 2003. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 63:573-578.
39. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, Robertson JW. 1998. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352:179-184.
40. Li C, Ansari R, Yu Z, Shah D. 2000. Definitive molecular evidence of reninangiotensin system in human uterine decidual cells. Hypertension 36:159-164.
41. Martinez E, Puras A, Escribano J, Sanchis C, Carrion L, Artigao M, Divison JA, Masso J, Vidal A, Fernandez JA. 2000. Angiotensin-converting enzyme (ACE) gene polymorphisms, serum ACE activity and blood pressure in a Spanish-Mediterranean population. J Hum Hypertens 14:131-135.
42. Matsubara M, Suzuki M, Fujiwara T, Kikuya M, Metoki H, Michimata M, Araki T, Kazama I, Satoh T, Hashimoto J, Hozawa A, Ohkubo T, Tsuji I, Katsuya T, Higaki J, Ogihara T, Satoh H, Imai Y. 2002. Angiotensin-converting enzyme I/D polymorphism and hypertension: The Ohasama study. J Hypertens 20:1121-1126.
43. McKenzie CA, Abecasis GR, Keavney B, Forrester T, Ratcliffe PJ, Julier C, Connell JM, Bennett F, McFarlane-Anderson N, Lathrop GM, et al. 2001. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 10:1077-1084.
44. Medeiros R, Vasconcelos A, Costa S, Pinto D, Lobo F, Morais A, Oliveira J, Lopes C. 2004. Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 202:330-335.
45. Mello G, Parretti E, Gensini F, Sticchi E, Mecacci F, Scarselli G, Genuardi M, Abbate R, Fatini C. 2003. Maternal-fetal flow, negative events, and preeclampsia: Role of ACE I/D polymorphism. Hypertension 41:932-937.
46. Mondorf UF, Russ A, Wiesemann A, Herrero M, Oremek G, Lenz T. 1998. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension. Am J Hypertens 11:174-183.
47. Moore JH, Lamb JM, Brown NJ, Vaughan DE. 2002. A comparison of combinatorial partitioning and linear regression for the detection of epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 levels. Clin Genet 62:74-79.
48. Moriyama T, Kitamura H, Ochi S, Izumi M, Yokoyama K, Yamauchi A, Ueda N, Kamada T, Imai E. 1995. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 6:1676-1678.
49. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. 1994. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 90:2199-2202.
50. Omran H, Haffner K, Vollmer M, Pigulla J, Wagner G. Caridi G. Hildebrandt F. 1999. Exclusion of the candidate genes ACE and Bcl-2 for six families with nephronophthisis not linked to the NPH1 locus. Nephrol Dial Transplant 14:2328-2331.
51. Parsa A, Peden E, Lum RF, Seligman VA, Olson JL, Li H, Seldin MF, Criswell LA. 2002. Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: Analysis of 644 SLE families. Genes Immun 1:S42-S46.
52. Reddy MK, Baskaran K, Molteni A. 1995. Inhibitors of angiotensin- converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc Soc Exp Biol Med 210:221-226.
53. Rieder MJ, Taylor SL, Clark AG, Nickerson DA. 1999. Sequence variation in the human angiotensin converting enzyme. Nat Genet 22:59-62.
54. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, Witteman JC. 2003. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: A meta-analysis. Stroke 34:1634-1639.
55. Schauser KH, Nielssn AH, Dantzer V, Poulsen K. 2001. Angiotensin- converting enzyme activity in the bovine uteroplacental unit changes in relation to the cycle and pregnancy. Placenta 22:852-862.
56. Schurmann M, Reichel P, Muller-Myhsok B, Dieringer T, Wurm K, Schlaak M, Muller-Quernheim J, Schwinger E. 2001. Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis. J Intern Med 249:77-83.
57. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. 2003. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: A meta-analysis. Arterioscler Thromb Vasc Biol 23:1269-1275.
58. Shintani S, Matsuo K, Crohin CC, McBride J, Tsuji T, Donoff RB, Posner M, Todd R, Wong DT. 1999. Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Res 59:4142-4147.
59. Shirasawa S, Harada H, Furugaki K, Akamizu T, Ishikawa N, Ito K, Ito K, Tamai H, Kuma K, Kubota S, et al. 2004. SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum Mol Genet 13:2221-2231.
60. Small W, Molteni A, Kim YT, Taylor JM, Chen Z, Ward WF. 1997. Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture. Breast Cancer Res Treat 44:217-224.
61. Strathy JH, Molgaard CA, Coulam CB, Melton LJ III. 1982. Endometriosis and infertility: A laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril 38:667-672.
62. Strawn EY Jr, Novy MJ, Burry KA, Bethea CL. 1995. Insulin-like growth factor I promotes leiomyoma cell growth in vitro. Am J Obstet Gynecol 172:1837-1844.
63. Tamura T, Johanning GL, Goldenberg RL, Johnston KE, DuBard MB. 1996. Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration. Obstet Gynecol 88:497-502.
64. Toblli JE, Cao G, DeRosa G, Di Gennaro F, Forcada P. 2004. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Am J Hypertens 17:172-180.
65. Treloar SA, O'Connor DT, O'Connor VM, Martin NG. 1999. Genetic influences on endometriosis in an Australian twin sample. Fertil Steril 71:701-710.
66. Um JY, An NH, Kim SH, Lee KM, Kim YS, Jang H, Cho KH, Moon BS, Kim HM. 2003. Genetic susceptibility to ischemic cerebrovascular disease in Koreans. J Mol Neurosci 20:31-38.
67. Vigano P, Gaffuri B, Somigliana E, Busacca M, Di Blasio AM, Vignali M. 1998. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 4:1150-1156.
68. Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Polverini PJ, Bouck NP. 1998. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 98:671-679.
69. Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M. 2003. Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J 17:2061-2067.
70. West MJ, Summers KM, Wong KK, Burstow DJ. 1997. Renin-angiotensin system gene polymorphisms and left ventricular hypertrophy. The case against an association. Adv Exp Med Biol 432:117-122.
71. Yamamoto K, Kataoka S, Hashimoto N, Kakihara T, Tanaka A, Kawasaki T, kikuchi T, Takahashi H, Uchiyama M. 1997. Serum level and gene polymorphism of angiotensin I converting enzyme in Japanese children. Acta Paediatr Jpn 39:1-5.
72. Yasumatsu R, Nakashima T, Masuda M, Ito A, Kuratomi Y, Nakagawa T, Komune S. 2004. Effects of the angiotenain-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol 130: 567-573.
73. Yildiz A, Yazici H, Cine N, Kazancioglu R, Akkaya V, Sever MS, Ark E, Erginel-Unaltuna N. 2003. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis. J Nephrol 16:399-403.
74. Zee RY, Lou YK, Griffiths LR, Morris BJ. 1992. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 184:9-15.
75. Zhu X, Bouzekri N, Southern L, Cooper RS, Adeyemo A, McKenzie CA, Luke A, Chen G, Elston RC, Ward R. 2001. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 68:1139-1148.